A Open-label Study to Assess Response to COVID-19 Vaccine in Multiple Sclerosis Participants Treated With Ofatumumab
- Status
- TERMINATED
- Phase
- PHASE4
Clinical Trials Related to Novartis Pharmaceuticals
Related studies linked through entity extraction aliases.
Asciminib Roll-over Study
- Status
- RECRUITING
- Phase
- PHASE4
Management of LDL-cholesterol With Inclisiran + Usual Care Compared to Usual Care Alone in Participants With a Recent Acute Coronary Syndrome
- Status
- COMPLETED
- Phase
- PHASE3
Exploring the Immune Response to SARS-CoV-2 COVID-19 Vaccines in Patients With Relapsing Multiple Sclerosis (RMS) Treated With Ofatumumab
- Status
- COMPLETED
- Phase
- PHASE4
Study of Safety, Tolerability and Efficacy of DFV890 in Participants With Familial Cold Auto-inflammatory Syndrome (FCAS)
- Status
- COMPLETED
- Phase
- PHASE2
Study of Efficacy, Safety, and Tolerability of LNA043 in Patients With Knee Osteoarthritis
- Status
- TERMINATED
- Phase
- PHASE2
Pilot Decentralized Clinical Trial in Men and Pre and Post-menopausal Women With Breast Cancer and a Specific Mutation (PIK3CA) Treated With Alpelisib in Combination With Fulvestrant
- Status
- TERMINATED
- Phase
- PHASE2
A Phase I Study of IAG933 in Patients With Advanced Mesothelioma and Other Solid Tumors
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Safety and Efficacy of Intravenous OAV101 (AVXS-101) in Pediatric Patients With Spinal Muscular Atrophy (SMA)
- Status
- COMPLETED
- Phase
- PHASE3
Observation of Treatment Patterns With Lucentis® in Real-life Conditions in All Approved Indications
- Status
- COMPLETED
- Phase
- N/A
A Multicenter Study to Assess Response to COVID-19 Vaccine in Multiple Sclerosis Participants Treated With Ofatumumab
- Status
- COMPLETED
- Phase
- N/A
Study of Diagnostic Performance of [18F]CTT1057 for PSMA-positive Tumors Detection
- Status
- COMPLETED
- Phase
- PHASE2/PHASE3
Study of Diagnostic Performance of [18F]CTT1057 in BCR
- Status
- COMPLETED
- Phase
- PHASE3
Managed Access Programs for ETB115, Eltrombopag
- Status
- AVAILABLE
- Phase
- N/A
A Study to Assess the Efficacy and Safety of CMK389 in Patients With Moderate to Severe Atopic Dermatitis.
- Status
- COMPLETED
- Phase
- PHASE2
A Dose Finding, Efficacy and Safety Study of Ensovibep (MP0420) in Ambulatory Adult Patients With Symptomatic COVID-19
- Status
- TERMINATED
- Phase
- PHASE2/PHASE3
Study of Efficacy and Safety of Twice Daily Oral Iptacopan (LNP023) in Adult PNH Patients Who Are Naive to Complement Inhibitor Therapy
- Status
- COMPLETED
- Phase
- PHASE3
Study of Efficacy and Safety of Iptacopan in Patients With C3 Glomerulopathy.
- Status
- RECRUITING
- Phase
- PHASE3
Study Evaluating Efficacy and Safety of Capmatinib in Combination With Osimertinib in Adult Subjects With Non-small Cell Lung Cancers as Second Line Therapy
- Status
- TERMINATED
- Phase
- PHASE3
A Safety and Efficacy Study of Anti-inflammatory (Canakinumab) and Cartilage Stimulating (LNA043) Drugs Injected Into the Knee Joint of Participants With Knee Osteoarthritis (OA)
- Status
- TERMINATED
- Phase
- PHASE2